Market Place
Sourcing Support
FDA issues warning letter after GLP-1 manufacturer
23 Apr 2026 //
FDA
Onesource And Orbicular Secure USFDA Tentative Approval
21 Apr 2026 //
EXPRESSPHARMA
Ozempic, Mounjaro Weight-Loss Drug Demand Surges In India
19 Apr 2026 //
ECONOMICTIMES
India`s Hetero Targets Annual Sales of 1.5 mln Semaglutide Pens
17 Apr 2026 //
REUTERS
Dr Reddy`s Gets Nod To Roll Out Generic Oral Semaglutide Drug
16 Apr 2026 //
PRESS RELEASE
Wegovy-maker Novo Nordisk partners with OpenAI
16 Apr 2026 //
REUTERS
MSN Labs Launches SEMABEST Semaglutide in India After CDSCO Nod
15 Apr 2026 //
EXPRESSPHARMA
Emcure Pharma Adjusts Poviztra Semaglutide Injection Price
15 Apr 2026 //
EXPRESSPHARMA
GoodRx Introduces Wegovy HD At $399/Month Self-Pay Rate
15 Apr 2026 //
PHARMIWEB
MHRA Approves Single-Dose Injection Device For Wegovy 7.2Mg
14 Apr 2026 //
PHARMIWEB
Retatrutide Ignites Buzz on Weight Loss, Longevity
13 Apr 2026 //
ECONOMICTIMES
The GLP-1 Revolution
13 Apr 2026 //
EXPRESSPHARMA
Apotex Gets Initial U.S. FDA Nod For Generic Ozempic
12 Apr 2026 //
PR NEWSWIRE
IPM Hits Growth in March as Semaglutide Generics Spark gold Rush
11 Apr 2026 //
PHARMABIZ
Mounjaro Sales Decline Due To Semaglutide Generics` Rise
10 Apr 2026 //
ECONOMICTIMES
Novo Nordisk launches higher-dose Wegovy in the United States
10 Apr 2026 //
PRNEWSWIRE
Generic Drugmakers Rush As Novo Nordisk Loses Weight-Loss Drug
09 Apr 2026 //
ECONOMICTIMES
Novo`s Wegovy: First EU-Approved GLP-1 for 48-Week Use
09 Apr 2026 //
GLOBENEWSWIRE
23andMe Study Identifies Genetic Predictors of GLP-1 Weight Loss
08 Apr 2026 //
GLOBENEWSWIRE
Apotex’s Generics Semaglutide Receives Tentative Approval in US
07 Apr 2026 //
FDA
Experts Recommend Comprehensive Semaglutide Utilization
06 Apr 2026 //
INDPHARMAPOST
Government Initiates Safety Review Of Popular Weight-Loss Drugs
04 Apr 2026 //
ECONOMICTIMES
Patent Expiries Ahead, Is India Pharma Inc Ready?
03 Apr 2026 //
EXPRESSPHARMA
Emcure Pharma Cuts Poviztra Starting Dose Price By 55% In India
02 Apr 2026 //
INDPHARMAPOST
Midst Global Headwinds, CDSCO Cracks Down On GLP-1 Gold Rush
01 Apr 2026 //
EXPRESSPHARMA
UK Cost Watchdog Clears Novo`s Wegovy For Cardio Risk Reduction
01 Apr 2026 //
FIERCE PHARMA
India`s Weight Management Market Growth Raises Risk
31 Mar 2026 //
BUSINESS STD
Novo Nordisk Slashes Ozempic, Wegovy Prices by Up to 48% in India
31 Mar 2026 //
ECONOMICTIMES
Novo Nordisk Plans To Cut Price Of Ozempic As Generics Hit Market
31 Mar 2026 //
ECONOMICTIMES
Bionxt Progresses Semaglutide In First GLP-1 ODF Platform Move
30 Mar 2026 //
PHARMIWEB
Alkem Labs Introduces Cost-Effective Semaglutide Injection
26 Mar 2026 //
INDPHARMAPOST
Vivani Medical Reveals 2025 Financials And Business Update
26 Mar 2026 //
GLOBENEWSWIRE
Telangana DCA Issues Safety Advisory On Use Of Semaglutide
26 Mar 2026 //
PHARMABIZ
Novo Nordisk Triple Agonist UBT251 Cuts HbA1c by 2.16% in Phase 2
25 Mar 2026 //
GLOBENEWSWIRE
Novo Faces Access Challenges Despite Strong Wegovy Launch
25 Mar 2026 //
BIOSPACE
Government Enhances Oversight On Unauthorized GLP-1 Sales
24 Mar 2026 //
BUSINESS STD
GLP-1 Rush: Pharma, Food Firms Eye Tie-Ups For Weight-Loss Boom
23 Mar 2026 //
ECONOMICTIMES
Indian Drugmakers Flood Market With Cheap Ozempic, Wegovy Copies
23 Mar 2026 //
ECONOMICTIMES
USV Launches `Usema` To Address India`s Metabolic Health Burden
23 Mar 2026 //
EXPRESSPHARMA
Novo To Track Generic Surge As Semaglutide Goes Off Patent
21 Mar 2026 //
ECONOMICTIMES
ReflexMD Evaluates Safety Risks Of GLP-1 Claims For Semaglutide
20 Mar 2026 //
GLOBENEWSWIRE
Novo To Track Generic Surge As Semaglutide Goes Off Patent
20 Mar 2026 //
ECONOMICTIMES
Natco Launches Rs 1,290 Semaglutide Following Novo Nordisk
20 Mar 2026 //
ECONOMICTIMES
Natco`s Rs1,290 Semaglutide Slashes Diabetes Drug Prices in India
20 Mar 2026 //
ECONOMICTIMES
Eris Launches Weekly Semaglutide Shot At ?220/Shot
20 Mar 2026 //
EXPRESSPHARMA
FDA Approves Wegovy HD to Maximize Weight Loss
20 Mar 2026 //
PR NEWSWIRE
Delhi HC Requests Govt Response On Delay In Off-Label Ozempic
18 Mar 2026 //
ECONOMICTIMES
Zydus & Torrent Pharma Partner To Co-Market Semaglutide Injection
18 Mar 2026 //
ECONOMICTIMES
Semaglutide Boom In India Marks Turning Point For GLP-1 Drugs
18 Mar 2026 //
EXPRESSPHARMA
Zydus, Lupin Partner to Co-Market Semaglutide in India
17 Mar 2026 //
ECONOMICTIMES
Ozempic Generics Set To Disrupt India`s Weight-Loss Market
15 Mar 2026 //
ECONOMICTIMES
Mankind Pharma Targets Early Semaglutide Launch
15 Mar 2026 //
ECONOMICTIMES
TIXiMED Reveals Oral TIX100 Prevents Weight Regain Post GLP-1
10 Mar 2026 //
PHARMIWEB
Hoth` HT-VA Restores Cholesterol Levels In MASLD Model
10 Mar 2026 //
PR NEWSWIRE
Novo Nordisk Boosts Semaglutide Over Eli Lilly In Market Share
09 Mar 2026 //
ECONOMICTIMES
Veru Enrolls 1st Patient In Trial For Enobosarm & Semaglutide
09 Mar 2026 //
GLOBENEWSWIRE
Direct Meds Releases 2026 Report on Semaglutide, Tirzepatide
09 Mar 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk Again For Misleading GLP-1 AD
05 Mar 2026 //
RAPS
Ahead Of Its Time, A GLP-1 Drug Almost Made It Out Of India
04 Mar 2026 //
ECONOMICTIMES
Novo Allocates $506M To Convert Irish Plant For Oral Wegovy
02 Mar 2026 //
BIOSPACE
